In this consecutive case series (n = 149) from the Breast Cancer Risk and Lifestyle (BCRL) study, plasma levels of pro‐angiogenic factors, including VEGF‐C, ANGs, and Tie‐2, were assessed using ELISA. The gene discussed is VEGFC; the disease is breast carcinoma.